Anastomosis Complications after Bronchoplasty: Incidence, Risk Factors, and Treatment Options Reported by a Referral Cancer Center.

anastomotic complications bronchoplasty bronchoscopy lung cancer sleeve resections

Journal

Current oncology (Toronto, Ont.)
ISSN: 1718-7729
Titre abrégé: Curr Oncol
Pays: Switzerland
ID NLM: 9502503

Informations de publication

Date de publication:
12 Dec 2023
Historique:
received: 14 11 2023
revised: 30 11 2023
accepted: 06 12 2023
medline: 22 12 2023
pubmed: 22 12 2023
entrez: 22 12 2023
Statut: epublish

Résumé

Sleeve lobectomy with bronchoplasty is a safe surgical technique for the management of lung cancer and endobronchial localization of extrapulmonary cancers. However, anastomotic complications can occur, and treatment strategies are not standardized. Data from 280 patients subjected to bronchoplasty were retrospectively analyzed, focusing on surgical techniques, anastomotic complications, and their management. Multivariate analysis was performed, and Kaplan-Meier curves were used to determine survival. Ninety percent of 280 surgeries were for lung cancer. Anastomotic complications occurred in 6.42% of patients: late stenosis in 3.92% and broncho-pleural fistula in 1.78%. The median survival was 65.90 months (95% CI = 41.76-90.97), with no difference ( In our experience, surgery is preferred to avoid life-threatening complications in bronchopleural fistulas. Bronchoscopic balloon dilatation is preferred for benign strictures. The nodal stage is related to complications (

Sections du résumé

BACKGROUND BACKGROUND
Sleeve lobectomy with bronchoplasty is a safe surgical technique for the management of lung cancer and endobronchial localization of extrapulmonary cancers. However, anastomotic complications can occur, and treatment strategies are not standardized.
METHODS METHODS
Data from 280 patients subjected to bronchoplasty were retrospectively analyzed, focusing on surgical techniques, anastomotic complications, and their management. Multivariate analysis was performed, and Kaplan-Meier curves were used to determine survival.
RESULTS RESULTS
Ninety percent of 280 surgeries were for lung cancer. Anastomotic complications occurred in 6.42% of patients: late stenosis in 3.92% and broncho-pleural fistula in 1.78%. The median survival was 65.90 months (95% CI = 41.76-90.97), with no difference (
CONCLUSIONS CONCLUSIONS
In our experience, surgery is preferred to avoid life-threatening complications in bronchopleural fistulas. Bronchoscopic balloon dilatation is preferred for benign strictures. The nodal stage is related to complications (

Identifiants

pubmed: 38132394
pii: curroncol30120760
doi: 10.3390/curroncol30120760
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

10437-10449

Auteurs

Lara Girelli (L)

Division of Thoracic Surgery, IEO, European Institute of Oncology, IRCCS, 20141 Milan, Italy.

Luca Bertolaccini (L)

Division of Thoracic Surgery, IEO, European Institute of Oncology, IRCCS, 20141 Milan, Italy.

Monica Casiraghi (M)

Division of Thoracic Surgery, IEO, European Institute of Oncology, IRCCS, 20141 Milan, Italy.
Department of Oncology and Hematology-Oncology, University of Milan, 20141 Milan, Italy.

Francesco Petrella (F)

Division of Thoracic Surgery, IEO, European Institute of Oncology, IRCCS, 20141 Milan, Italy.
Department of Oncology and Hematology-Oncology, University of Milan, 20141 Milan, Italy.

Domenico Galetta (D)

Division of Thoracic Surgery, IEO, European Institute of Oncology, IRCCS, 20141 Milan, Italy.
Department of Oncology and Hematology-Oncology, University of Milan, 20141 Milan, Italy.

Antonio Mazzella (A)

Division of Thoracic Surgery, IEO, European Institute of Oncology, IRCCS, 20141 Milan, Italy.

Stefano Donghi (S)

Interventional Pneumology Unit, IEO, European Institute of Oncology, IRCCS, 20141 Milan, Italy.

Giorgio Lo Iacono (G)

Division of Thoracic Surgery, IEO, European Institute of Oncology, IRCCS, 20141 Milan, Italy.

Andrea Cara (A)

Division of Thoracic Surgery, IEO, European Institute of Oncology, IRCCS, 20141 Milan, Italy.

Juliana Guarize (J)

Interventional Pneumology Unit, IEO, European Institute of Oncology, IRCCS, 20141 Milan, Italy.

Lorenzo Spaggiari (L)

Division of Thoracic Surgery, IEO, European Institute of Oncology, IRCCS, 20141 Milan, Italy.
Department of Oncology and Hematology-Oncology, University of Milan, 20141 Milan, Italy.

Classifications MeSH